Opportunities in Emerging Economies for the Heart Failure POC & LOC Devices Market
The growing burden of cardiovascular diseases makes cost-effective diagnostic solutions a necessity. The Heart Failure POC & LOC Devices Market offers affordable alternatives to traditional laboratory-based testing, making cardiac care more accessible.
The global market was valued at USD 110.5 million in 2021 and is projected to reach USD 225.1 million by 2030, advancing at a CAGR of 8.2%. A significant part of this expansion comes from healthcare providers adopting devices that reduce costs without compromising diagnostic accuracy.
By offering rapid results at the point of care, POC and LOC devices cut down on hospital admissions, repeated consultations, and long laboratory wait times. This not only reduces patient expenses but also eases the burden on healthcare systems.
Emerging economies particularly benefit from cost-effective devices, as limited laboratory infrastructure often creates gaps in early diagnosis. Portable diagnostic solutions bridge these gaps, enabling better disease management at lower costs.
The market’s focus on affordability, alongside advanced technology, is reshaping how cardiac diagnostics are delivered globally.